Agios Pharmaceuticals, Inc. (LON:0HB0)
London · Delayed Price · Currency is GBP · Price in USD 36.47
+0.26 (0.71%)
At close: Sep 15, 2025
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of 1.56 billion as of September 17, 2025. Its market cap has decreased by -20.03% in one year.
Market Cap
1.56B
Enterprise Value
617.59M
Revenue
29.83M
Ranking
n/a
PE Ratio
3.29
Stock Price
36.47
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from 613.73M to 1.56B, an increase of 154.72%. That is a compound annual growth rate of 8.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.55B | 3.60% |
| Dec 31, 2024 | 1.50B | 53.18% |
| Dec 29, 2023 | 977.19M | -23.69% |
| Dec 30, 2022 | 1.28B | -2.87% |
| Dec 31, 2021 | 1.32B | -40.02% |
| Dec 31, 2020 | 2.20B | -10.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.00B |
| GSK plc | 59.54B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.65B |